1. Home
  2. FSFG vs CHRS Comparison

FSFG vs CHRS Comparison

Compare FSFG & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Savings Financial Group Inc.

FSFG

First Savings Financial Group Inc.

HOLD

Current Price

$32.33

Market Cap

221.5M

Sector

Finance

ML Signal

HOLD

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

HOLD

Current Price

$1.39

Market Cap

186.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSFG
CHRS
Founded
2008
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
221.5M
186.0M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
FSFG
CHRS
Price
$32.33
$1.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$31.50
$4.02
AVG Volume (30 Days)
14.1K
963.8K
Earning Date
01-27-2026
11-06-2025
Dividend Yield
1.93%
N/A
EPS Growth
67.68
N/A
EPS
3.32
1.34
Revenue
$84,223,000.00
$277,728,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$67.29
P/E Ratio
$10.00
$1.02
Revenue Growth
23.11
152.07
52 Week Low
$21.63
$0.71
52 Week High
$33.35
$1.89

Technical Indicators

Market Signals
Indicator
FSFG
CHRS
Relative Strength Index (RSI) 65.38 53.23
Support Level $32.86 $1.31
Resistance Level $33.35 $1.41
Average True Range (ATR) 0.47 0.09
MACD 0.08 0.02
Stochastic Oscillator 81.56 77.34

Price Performance

Historical Comparison
FSFG
CHRS

About FSFG First Savings Financial Group Inc.

First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.

Share on Social Networks: